4.10
price up icon2.50%   0.10
after-market Dopo l'orario di chiusura: 4.10
loading

Molecular Partners Ag Adr Borsa (MOLN) Ultime notizie

pulisher
Oct 30, 2025

Molecular Partners Reports Q3 2025 Financial Results and Clinical Progress, with DLL3-Targeting Radio-DARPin MP0712 Phase 1 Launch Expected in 2025 - GlobeNewswire Inc.

Oct 30, 2025
pulisher
Oct 11, 2025

Molecular Partners (NASDAQ:MOLN) Stock Price Down 2.1% – Here’s What Happened - Defense World

Oct 11, 2025
pulisher
Oct 10, 2025

Molecular Partners AG (MOLNZ.XC) Stock Price, News, Quote & History - Yahoo

Oct 10, 2025
pulisher
Sep 22, 2025

Molecular Partners (NASDAQ:MOLN) Trading 1.5% HigherHere's What Happened - MarketBeat

Sep 22, 2025
pulisher
Sep 11, 2025

Liminatus Pharma (LIMN) Short Interest Ratio and Volume 2025 - MarketBeat

Sep 11, 2025
pulisher
Sep 08, 2025

Molecular Partners (NASDAQ:MOLN) Price Target Cut to $4.00 by Analysts at JPMorgan Chase & Co. - MarketBeat

Sep 08, 2025
pulisher
Sep 02, 2025

Leerink Partnrs Has Bullish Estimate for MOLN Q3 Earnings - MarketBeat

Sep 02, 2025
pulisher
Aug 29, 2025

Leerink Partnrs Issues Positive Outlook for MOLN Earnings - Defense World

Aug 29, 2025
pulisher
Aug 26, 2025

EHang, Molecular Partners And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

Aug 26, 2025
pulisher
Aug 26, 2025

Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket - Benzinga

Aug 26, 2025
pulisher
Jul 16, 2025

Molecular Partners Ag shares rise 3.64% intraday after Voyager Therapeutics expands Alzheimer's disease franchise. - AInvest

Jul 16, 2025
pulisher
Jul 02, 2025

Molecular Partners (NASDAQ:MOLN) Stock Price Down 3.4% – Should You Sell? - Defense World

Jul 02, 2025
pulisher
Jun 22, 2025

Molecular Partners and Orano Med Present Promising Preclinical Data on MP0726, a Radio-DARPin Candidate for Ovarian Cancer Treatment - AInvest

Jun 22, 2025
pulisher
Jun 11, 2025

Molecular Partners shares rise 1.93% after-hours after presenting positive data from ongoing Phase 1/2A trial. - AInvest

Jun 11, 2025
pulisher
Jun 10, 2025

Molecular Partners Cuts 40 Jobs, Extends Cash Reach to 2028 - AInvest

Jun 10, 2025
pulisher
Jun 06, 2025

Molecular Partners Ag shares rise 6.71% intraday after MIT and Recursion release Boltz-2 AI model. - AInvest

Jun 06, 2025
pulisher
May 22, 2025

US NYSE/NASD Stock Directory - Minichart

May 22, 2025
pulisher
May 14, 2025

Walmart, Deere, Applied Materials set to report earnings Thursday - Investing.com

May 14, 2025
pulisher
Apr 25, 2025

Molecular Partners' AACR 2025 Breakthroughs: Radio-DARPins and Smart T Cell Engagers Ignite Oncology Potential - AInvest

Apr 25, 2025
pulisher
Mar 28, 2025

J.P. Morgan Keeps Their Buy Rating on Novo Nordisk (0QIU) - The Globe and Mail

Mar 28, 2025
pulisher
Mar 14, 2025

TD Cowen maintains Buy on Molecular Partners, target CHF15 - Investing.com

Mar 14, 2025
pulisher
May 26, 2024

Molecular Partners (MOLN) Stock Trends and Sentiment 2025 - MarketBeat

May 26, 2024
pulisher
May 11, 2024

Molecular Partners (MOLN) Stock Forecast and Price Target 2025 - MarketBeat

May 11, 2024
pulisher
Apr 17, 2024

Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting By Investing.com - Investing.com South Africa

Apr 17, 2024
pulisher
Apr 02, 2024

symbol__ Stock Quote Price and Forecast - CNN

Apr 02, 2024
pulisher
Apr 20, 2023

Molecular Partners: Sellers Have Disappeared, Enterprise Value Below Zero (NASDAQ:MOLN) - Seeking Alpha

Apr 20, 2023
pulisher
Sep 06, 2022

What is the current Price Target and Forecast for Molecular Partners AG Sponsored ADR (MOLN) - Zacks Investment Research

Sep 06, 2022
pulisher
Apr 24, 2022

US stock market gainers for the last week of April 2022 - Nairametrics

Apr 24, 2022
pulisher
Jan 10, 2022

Novartis and Molecular Partners report positive topline data from Phase 2 study for ensovibep (MP0420), a DARPin antiviral therapeutic for COVID-19 - Novartis

Jan 10, 2022
pulisher
Oct 11, 2021

Molecular Partners (MOLN) 10K Form and SEC Filings 2025 - MarketBeat

Oct 11, 2021
pulisher
Aug 26, 2021

Evaxion A/S (EVAX) Short Interest & Short Float | Updated Nov 2025 - MarketBeat

Aug 26, 2021
pulisher
Jun 21, 2021

Citi Appointed as Depositary Bank for Molecular Partners AG’s ADR Programme - Business Wire

Jun 21, 2021
pulisher
Jun 18, 2021

Molecular Partners AG Sponsored ADR (MOLN) - Zacks Investment Research

Jun 18, 2021
pulisher
Jun 16, 2021

Molecular Partners (MOLN) Earnings Date and Reports 2025 - MarketBeat

Jun 16, 2021
pulisher
Jun 16, 2021

Molecular Partners (MOLN) Competitors and Alternatives 2025 - MarketBeat

Jun 16, 2021
pulisher
Jun 16, 2021

Molecular Partners (MOLN) Stock Price, News & Analysis - MarketBeat

Jun 16, 2021
pulisher
Jun 15, 2021

MOLN Stock Price and Chart — NASDAQ:MOLN - TradingView

Jun 15, 2021
pulisher
May 27, 2021

Novartis and Molecular Partners announce start of EMPATHY clinical trial for ensovibep for the treatment of COVID-19 - Novartis

May 27, 2021
pulisher
May 10, 2021

Valneva SE (VALN) Stock Price, News, Quote & History - Yahoo

May 10, 2021
pulisher
Oct 28, 2020

Novartis announces collaboration with Molecular Partners to develop two DARPin® therapies designed for potential use against COVID-19 - Novartis

Oct 28, 2020
pulisher
Aug 10, 2020

Applied Therapeutics (APLT) Short Interest & Short Float | Updated Nov 2025 - MarketBeat

Aug 10, 2020
pulisher
Aug 09, 2020

PDS Biotechnology (PDSB) Short Interest Ratio and Volume 2025 - MarketBeat

Aug 09, 2020
pulisher
Apr 01, 2020

MLLCF News Today | Why did Molecular Partners stock go up today? - MarketBeat

Apr 01, 2020
pulisher
Oct 12, 2018

Conference Calls and Individual Investors - MarketBeat

Oct 12, 2018
pulisher
Sep 12, 2017

RocheDoing now what patients need next - Roche

Sep 12, 2017
pulisher
Jul 23, 2017

MOLN Stock Price and Chart — SIX:MOLN - TradingView

Jul 23, 2017
$39.84
price up icon 0.76%
$31.92
price up icon 1.66%
$105.65
price up icon 0.09%
$102.70
price up icon 3.00%
biotechnology ONC
$340.64
price up icon 1.63%
$204.51
price down icon 2.16%
Capitalizzazione:     |  Volume (24 ore):